| __timestamp | BioMarin Pharmaceutical Inc. | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 12404000 |
| Thursday, January 1, 2015 | 634806000 | 18343000 |
| Friday, January 1, 2016 | 661905000 | 18108000 |
| Sunday, January 1, 2017 | 610753000 | 17614000 |
| Monday, January 1, 2018 | 696328000 | 35619000 |
| Tuesday, January 1, 2019 | 715007000 | 58432000 |
| Wednesday, January 1, 2020 | 628116000 | 63945000 |
| Friday, January 1, 2021 | 628793000 | 72200000 |
| Saturday, January 1, 2022 | 649606000 | 76642000 |
| Sunday, January 1, 2023 | 746773000 | 57519000 |
| Monday, January 1, 2024 | 747184000 |
Data in motion
In the competitive world of pharmaceuticals, innovation is key. BioMarin Pharmaceutical Inc. and Evotec SE are two giants in this arena, each with a distinct approach to research and development (R&D) investment. Over the past decade, BioMarin has consistently outpaced Evotec in R&D spending, with an average annual investment nearly 15 times greater. In 2023, BioMarin's R&D expenses peaked at approximately $747 million, marking a 62% increase from 2014. In contrast, Evotec's R&D spending, while growing, reached about $58 million in 2023, a significant rise from $12 million in 2014. This disparity highlights BioMarin's aggressive strategy in pioneering new treatments, while Evotec focuses on strategic partnerships and collaborations. As the pharmaceutical landscape evolves, these investment trends offer a glimpse into the future of drug development and innovation.
Analyzing R&D Budgets: AbbVie Inc. vs BioMarin Pharmaceutical Inc.
Research and Development Investment: Novartis AG vs Evotec SE
Research and Development Investment: argenx SE vs Evotec SE
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
Research and Development Investment: Insmed Incorporated vs BioMarin Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Axsome Therapeutics, Inc.
Research and Development: Comparing Key Metrics for BioMarin Pharmaceutical Inc. and PTC Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs Evotec SE: A Gross Profit Performance Breakdown
Analyzing R&D Budgets: Pharming Group N.V. vs Evotec SE
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and Evotec SE
ADMA Biologics, Inc. or Evotec SE: Who Invests More in Innovation?
Vericel Corporation vs Evotec SE: Strategic Focus on R&D Spending